Congenital diaphragmatic hernias: from genes to mechanisms to therapies

Congenital diaphragmatic hernias (CDHs) and structural anomalies of the diaphragm are a common class of congenital birth defects that are associated with significant morbidity and mortality due to associated pulmonary hypoplasia, pulmonary hypertension and heart failure. In ∼30% of CDH patients, gen...

Full description

Bibliographic Details
Main Authors: Gabrielle Kardon, Kate G. Ackerman, David J. McCulley, Yufeng Shen, Julia Wynn, Linshan Shang, Eric Bogenschutz, Xin Sun, Wendy K. Chung
Format: Article
Language:English
Published: The Company of Biologists 2017-08-01
Series:Disease Models & Mechanisms
Subjects:
Online Access:http://dmm.biologists.org/content/10/8/955
_version_ 1818528181172305920
author Gabrielle Kardon
Kate G. Ackerman
David J. McCulley
Yufeng Shen
Julia Wynn
Linshan Shang
Eric Bogenschutz
Xin Sun
Wendy K. Chung
author_facet Gabrielle Kardon
Kate G. Ackerman
David J. McCulley
Yufeng Shen
Julia Wynn
Linshan Shang
Eric Bogenschutz
Xin Sun
Wendy K. Chung
author_sort Gabrielle Kardon
collection DOAJ
description Congenital diaphragmatic hernias (CDHs) and structural anomalies of the diaphragm are a common class of congenital birth defects that are associated with significant morbidity and mortality due to associated pulmonary hypoplasia, pulmonary hypertension and heart failure. In ∼30% of CDH patients, genomic analyses have identified a range of genetic defects, including chromosomal anomalies, copy number variants and sequence variants. The affected genes identified in CDH patients include transcription factors, such as GATA4, ZFPM2, NR2F2 and WT1, and signaling pathway components, including members of the retinoic acid pathway. Mutations in these genes affect diaphragm development and can have pleiotropic effects on pulmonary and cardiac development. New therapies, including fetal endoscopic tracheal occlusion and prenatal transplacental fetal treatments, aim to normalize lung development and pulmonary vascular tone to prevent and treat lung hypoplasia and pulmonary hypertension, respectively. Studies of the association between particular genetic mutations and clinical outcomes should allow us to better understand the origin of this birth defect and to improve our ability to predict and identify patients most likely to benefit from specialized treatment strategies.
first_indexed 2024-12-11T06:46:20Z
format Article
id doaj.art-901141c9574e40c49a93391a1c8d726a
institution Directory Open Access Journal
issn 1754-8403
1754-8411
language English
last_indexed 2024-12-11T06:46:20Z
publishDate 2017-08-01
publisher The Company of Biologists
record_format Article
series Disease Models & Mechanisms
spelling doaj.art-901141c9574e40c49a93391a1c8d726a2022-12-22T01:17:03ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112017-08-0110895597010.1242/dmm.028365028365Congenital diaphragmatic hernias: from genes to mechanisms to therapiesGabrielle Kardon0Kate G. Ackerman1David J. McCulley2Yufeng Shen3Julia Wynn4Linshan Shang5Eric Bogenschutz6Xin Sun7Wendy K. Chung8 Department of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA Departments of Pediatrics (Critical Care) and Biomedical Genetics, University of Rochester Medical Center, Rochester, NY 14642, USA Department of Pediatrics, University of Wisconsin, Madison, WI 53792, USA Department of Systems Biology, Columbia University Medical Center, New York, NY 10032, USA Departments of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA Departments of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA Department of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA Department of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA Congenital diaphragmatic hernias (CDHs) and structural anomalies of the diaphragm are a common class of congenital birth defects that are associated with significant morbidity and mortality due to associated pulmonary hypoplasia, pulmonary hypertension and heart failure. In ∼30% of CDH patients, genomic analyses have identified a range of genetic defects, including chromosomal anomalies, copy number variants and sequence variants. The affected genes identified in CDH patients include transcription factors, such as GATA4, ZFPM2, NR2F2 and WT1, and signaling pathway components, including members of the retinoic acid pathway. Mutations in these genes affect diaphragm development and can have pleiotropic effects on pulmonary and cardiac development. New therapies, including fetal endoscopic tracheal occlusion and prenatal transplacental fetal treatments, aim to normalize lung development and pulmonary vascular tone to prevent and treat lung hypoplasia and pulmonary hypertension, respectively. Studies of the association between particular genetic mutations and clinical outcomes should allow us to better understand the origin of this birth defect and to improve our ability to predict and identify patients most likely to benefit from specialized treatment strategies.http://dmm.biologists.org/content/10/8/955Structural birth defectsCongenital diaphragmatic hernia (CDH)DiaphragmPulmonary hypoplasiaPulmonary hypertensionCongenital heart disease (CHD)Genetics
spellingShingle Gabrielle Kardon
Kate G. Ackerman
David J. McCulley
Yufeng Shen
Julia Wynn
Linshan Shang
Eric Bogenschutz
Xin Sun
Wendy K. Chung
Congenital diaphragmatic hernias: from genes to mechanisms to therapies
Disease Models & Mechanisms
Structural birth defects
Congenital diaphragmatic hernia (CDH)
Diaphragm
Pulmonary hypoplasia
Pulmonary hypertension
Congenital heart disease (CHD)
Genetics
title Congenital diaphragmatic hernias: from genes to mechanisms to therapies
title_full Congenital diaphragmatic hernias: from genes to mechanisms to therapies
title_fullStr Congenital diaphragmatic hernias: from genes to mechanisms to therapies
title_full_unstemmed Congenital diaphragmatic hernias: from genes to mechanisms to therapies
title_short Congenital diaphragmatic hernias: from genes to mechanisms to therapies
title_sort congenital diaphragmatic hernias from genes to mechanisms to therapies
topic Structural birth defects
Congenital diaphragmatic hernia (CDH)
Diaphragm
Pulmonary hypoplasia
Pulmonary hypertension
Congenital heart disease (CHD)
Genetics
url http://dmm.biologists.org/content/10/8/955
work_keys_str_mv AT gabriellekardon congenitaldiaphragmaticherniasfromgenestomechanismstotherapies
AT kategackerman congenitaldiaphragmaticherniasfromgenestomechanismstotherapies
AT davidjmcculley congenitaldiaphragmaticherniasfromgenestomechanismstotherapies
AT yufengshen congenitaldiaphragmaticherniasfromgenestomechanismstotherapies
AT juliawynn congenitaldiaphragmaticherniasfromgenestomechanismstotherapies
AT linshanshang congenitaldiaphragmaticherniasfromgenestomechanismstotherapies
AT ericbogenschutz congenitaldiaphragmaticherniasfromgenestomechanismstotherapies
AT xinsun congenitaldiaphragmaticherniasfromgenestomechanismstotherapies
AT wendykchung congenitaldiaphragmaticherniasfromgenestomechanismstotherapies